Jumble Of Endpoints For Ophthalmic Surgery Analgesics Coming Into Focus At Panel Session
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Dermatologic and Ophthalmic Drugs Advisory Committee may help provide guidance in the increasingly competitive therapeutic space of postoperative ocular pain.